Discordance in p53 mutations when comparing ascites and solid tumors from patients with serous ovarian cancer

Tumor Biology

Volumn 18, Issue 3, 1997, Pages 167-174

  Provencher, Diane M ^a,b   Lounis, Hafida ^a   Fink, Dominique ^a   Drouin, Pierre ^a,b   Mes Masson, Anne Marie ^a,c  

^a Institut du Cancer de Montreal   (Canada)

^b Département d Obstétrique Gynécologie et   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Ascites; Cell culture; Ovarian serous carcinoma; p53

Indexed keywords

PROTEIN P53;

ARTICLE; ASCITES TUMOR; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0030996504     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000218027     Document Type: Article

References (30)

1. Whitman GF, Nolan TE, Gallup DG: Normal ovarian development and function; in Markman M, Hoskins WJ (eds): Cancer of the Ovary, New York, Raven Press, 1993, pp 1-21.
2. Morrow CP, Curtin JP, Townsend DE: Tumors of the ovary; Neoplasms derived from coelomic epithelium; in Synopsis of Gynecologic Oncology, ed 4, New York, Churchill Livingstone, 1993, pp 233-274.
3. Rubin SC, Finstad CL, Hoskins WJ, Provencher DM, Fcderici MG, Lloyd KO, Lewis JL Jr: Analysis of antigen expression at multiple tumor sites in epithelial ovarian cancer, Am J Obstet Gynecol 1991; 163: 558-563.
4. Provencher DM, Finstad CL, Saigo PE, Rubin SC, Hoskins WJ, Fcderici MG Stockcrt E, Lloyd KO, Lewis JL Jr: Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer (EOC), Gynecol Oncol 1993,50: 78-83.
5. Ilollstein M, Sidransky D, Vogel-stcin B, Harris CC: p53 mutations in human cancers, Science 1991;253: 49-53.
6. Henscl CH, Xiang RH, Sakaguchi AY, Naylor SL: Use of the single strand conformation polymorphism technique and PCR to detect p53 mutation in small lung cancer, Oncogene 1991:6:1067-1071.
7. Yamada Y, Yoshida T, Hayashi K, Sekiya T, Yokata J, Hirobashi S, Nakatani D, Nakano H, Sugimura T, Terada M: p53 gene mutations in gastric cancer métastasés and in gastric cancer cell lines derived from métastasés, Cancer Res 1991:51: 5800-5805.
8. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as singlc-strand conformation polymorphisms, Proc Natl Acad Sci USA 1989:86:2766-2770.
9. Okamoto A, Sameshima Y, Yokoya-ma S, Terashima Y, Sugimura T, Terada M, Yokota J: Frequent allelic losses and mutations of the p53 gene in human ovarian cancer, Cancer Res 1991;51:5171-5176.
10. Mazars R, Pujol P, Maudclonde T, Jcanteur P, Theillet C: p53 mutations in ovarian cancer: A late event? Oncogene 1991:6:1685-1690.
11. Milner BJ, Allan LA, Eccles DM, Kitchener HC, Leonard RCF, Kelly KF, Parkin DE, Haites NE: p53 mutation is a common genetic event in ovarian carcinoma, Cancer Res 1993;53:2128-2132.
12. Mok C-H, Tsao S-W, Knapp RC, Fishbaugh PM, Lau CC: Unifocal origin of advanced human epithelial ovarian cancers, Cancer Res 1992; 52:5119-5122.
13. Naito M, Satake M, Sakai E, Hirano Y, Tsuchida N, Kanzaki H, Ito Y, Mori T: Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis, Jpn J Cancer Res 1992:83:1030-1036.
14. Kihana T, Tsuda H, Tcshima S, Okada S, Matsuura S, Hirohashi S: High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA ancuploidy, Jpn J Cancer Res 1992:83:978-984.
15. Kupryjanczyk J, Thor AD, Beauchamp R, Merritt V, Edgerton SM, Bell DA, Yandell DW: p53 gene mutations and protein accumulation in human ovarian cancer, Proc Natl Acad Sci USA 1993:90:4961 -4965.
16. Kim JW, Cho YH, Kwon DJ, Kim TE, Park TC, Lee JM, Namkoong SE: Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma, Gynecol Oncol 1995:57:199-204.
17. Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BAJ, Humphrey P, Bcrchuck A, Ponder BAJ, Bast RC Jr: Clonal origin of epithelial ovarian carcinoma: Analysis by loss of heterozygosity, p53 mutation and X-chromosomc inactivation, J Natl Cancer Inst 1992;84:1793-1798.
18. Lounis H, Provcnchcr D, Godbout C, Fink D, Milot M-J, Mes-Masson A-M: Primary cultures of normal and tumoral human ovarian epithelium: A powerful tool for basic molecular studies, Exp Cell Res 1994; 215:303-309.
19. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2, New York, Cold Spring Harbor Laboratory, 1989.
20. Meitzer SJ, Mane SM, Wood PK, Johnson L, Needleman SW: Sequencing products of the PC'R directly, without purification, Bio-techniques 1990;8:142-148.
21. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain terminating inhibitors, Proc Natl Acad Sei USA 1977:74:5463-5467.
22. Lamb P, Crawford L: Characterization of the human p53 gene, Mol Cell Biol 1986;6:1379-1385.
23. Hcppner GH: Tumor hctcrogcnici-ty, Cancer Res 1984;44:2259-2265.
24. Hirabayashi K, Graham J: Genesis of ascites in ovarian cancer, Am J Obstct Gynecol 1970;106:492-497.
25. Teneriello MG, Ebina M, Linnoila RI, Henry- M, Nash JD, Park RC, Birrer MJ: p53 and Ki-ras gene mutations in epithelial ovarian neoplasm, Cancer Res 1993:53:3103- 3108.
26. Woodruff JD, Julian CG: Multiple malignancy in the upper genital tract, Am J Obstet Gynecol 1969; 193:810-822.
27. Rutledge ML, Silva EG, McLemore D, El Naggar A: Serous surface carcinoma of the ovary and peritoneum: A flow cytometric study, Pathol Annu 1989;24:227-235.
28. Skilling JS, Squatrito RC, Connor JP, Niemann T, Buller RE: p53 gene mutation analysis and antisense-me-diated growth inhibition of human ovarian carcinoma cell lines, Gynecol Oncol 1996;60:72-80.
29. Geisler JP, Wiemann MC, Zhou Z, Miller GA, Geisler HE: The difference in biological activity between the primary tumor and omental métastases in papillary serous carcinoma of the ovary, Gynecol Oncol 1996;60:139-140.
30. Chen P-L, Chen Y, Bookstcin R, Lee W-H: Genetic mechanisms of tumor suppression by the p53 gene, Science 1990;250:1576-1580.